Figures & data
Table 1 Summary of five articles from PubMed and EMBASE that were determined eligible using the keywords “COPD”, “eosinophil”, and “clinical trial” based on systematic review criteria
Figure 1 Forest plots of studies comparing the pooled risk ratio for moderate/severe exacerbation in patients with COPD receiving ICS-containing treatment or non-ICS/ICS withdrawal/placebo treatments by subgroup.
Note: (A) Eosinophil counts <2% and (B) eosinophil counts ≥2%.
Abbreviation: ICS, inhaled corticosteroid.
![Figure 1 Forest plots of studies comparing the pooled risk ratio for moderate/severe exacerbation in patients with COPD receiving ICS-containing treatment or non-ICS/ICS withdrawal/placebo treatments by subgroup.Note: (A) Eosinophil counts <2% and (B) eosinophil counts ≥2%.Abbreviation: ICS, inhaled corticosteroid.](/cms/asset/052979a8-11c7-4839-b01d-7a19a42606d9/dcop_a_175017_f0001_b.jpg)
Figure 2 Analysis of publication bias for pooled risk ratio of moderate/severe exacerbation for (A) eosinophil counts <2% and (B) eosinophil counts ≥2%.
![Figure 2 Analysis of publication bias for pooled risk ratio of moderate/severe exacerbation for (A) eosinophil counts <2% and (B) eosinophil counts ≥2%.](/cms/asset/b86cfe81-6ff0-4654-b187-857bdd79f50a/dcop_a_175017_f0002_c.jpg)
Figure 3 Forest plots of studies comparing the pooled hazard ratio for time-to-first moderate/severe exacerbation in patients with COPD receiving ICS-containing treatment or non-ICS/ICS withdrawal/placebo treatments by subgroup.
Note: (A) Eosinophil counts <2% and (B) eosinophil counts ≥2%.
Abbreviation: ICS, inhaled corticosteroid.
![Figure 3 Forest plots of studies comparing the pooled hazard ratio for time-to-first moderate/severe exacerbation in patients with COPD receiving ICS-containing treatment or non-ICS/ICS withdrawal/placebo treatments by subgroup.Note: (A) Eosinophil counts <2% and (B) eosinophil counts ≥2%.Abbreviation: ICS, inhaled corticosteroid.](/cms/asset/58da845e-d3e7-43c9-970f-72b3061015b1/dcop_a_175017_f0003_b.jpg)
Figure 4 Forest plots of studies comparing the pooled relative risk of pneumonia events in patients with COPD receiving ICS-containing treatment or non-ICS/ICS withdrawal/placebo treatments by subgroup.
Abbreviation: ICS, inhaled corticosteroid.
![Figure 4 Forest plots of studies comparing the pooled relative risk of pneumonia events in patients with COPD receiving ICS-containing treatment or non-ICS/ICS withdrawal/placebo treatments by subgroup.](/cms/asset/136b8441-5f30-464f-b891-15c3e20150a4/dcop_a_175017_f0004_b.jpg)